skip to Main Content

Using a Tumor’s Genomic Signature to Guide Radiation Therapy Doses

Newsfeed image, light gray text on dark gray background
Researchers at the Moffitt Cancer Center have developed a genomics model called genomic-adjusted radiation dose (GARD) that can guide the radiation dose to match a specific tumor’s radiosensitivity.

The model is expected to provide a framework for designing future clinical trials in radiation oncology… Read more . . .

Back To Top